A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal

BACKGROUND: Generalized anxiety disorder is characterized by excessive anxiety and worry about several events and activities. The estimated 1-year prevalence for adults is around 2% and the lifetime prevalence could reach more than 6%. The disease is associated with reduced quality of life, being co...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva Miguel, Luís, Silva Miguel, Nuno, Inês, Mónica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637226/
https://www.ncbi.nlm.nih.gov/pubmed/23587174
http://dx.doi.org/10.1186/1478-7547-11-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637226/
https://www.ncbi.nlm.nih.gov/pubmed/23587174
http://dx.doi.org/10.1186/1478-7547-11-8

Ejemplares similares